Last updated on 31 Oct 2022
Owner Info
Elixirgen Therapeutics, Inc.
855 N. Wolfe St. Suite 624
Baltimore, MD, 21205 UNITED STATES OF AMERICA,
Serial Number
2232614 filed on 1 Dec 2021
Correspondent
Spruson & Ferguson
GPO Box 3898,
Sydney, NSW, 2001 AUSTRALIA,
2232614
1 Dec 2021
1 Dec 2031
WORD
Status Date | Action Taken |
---|---|
31st Oct 2022 | IP Right Registered correspondence sent |
31st Oct 2022 | IP Right Registration Published |
31st Oct 2022 | Status change to Registered/Protected |
22nd Aug 2022 | Application Accepted correspondence sent |
22nd Aug 2022 | IP Right has been Examined |
22nd Aug 2022 | IP Right Acceptance Published |
22nd Aug 2022 | Status change to Accepted |
21st Jul 2022 | Examination Response Received |
16th Feb 2022 | Adverse Report (Examination) correspondence sent |
16th Feb 2022 | IP Right has been Examined |